PedAM
Pediatric Disease Annotations & Medicines
| Disease | aspergillosis |
| Phenotype | C0376545|hematological malignancies |
| Sentences | 10 |
| PubMedID- 23620764 | Invasive aspergillosis in patients with non-hematological malignancies is characterized by high mortality (60–100%) [6], [10], [11], which probably reflects the limitations of current diagnostic tools based on radiology or microbiology and the low index of clinical suspicion. |
| PubMedID- 23084969 | Invasive aspergillosis in patients with hematological malignancies in the czech and slovak republics: fungal infection database (find) analysis, 2005-2009. |
| PubMedID- 21905944 | Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies. |
| PubMedID- 25473570 | Invasive aspergillosis can be associated with hematological malignancies. |
| PubMedID- 21108574 | Comparison of pcr-elisa and real-time pcr for invasive aspergillosis diagnosis in patients with hematological malignancies. |
| PubMedID- 20367932 | [combination of real-time polymerase chain reaction assay and serum galactomannan in the diagnosis of invasive aspergillosis in patients with hematological malignancies and recipients of hematopoietic stem cell transplantation]. |
| PubMedID- 21417869 | Invasive aspergillosis in children with hematological malignancies. |
| PubMedID- 26126706 | Background: we assessed the diagnostic value of standard clinical methods and combined biomarker testing (galactomannan assay and polymerase chain reaction screening) in a prospective case-control study to detect invasive pulmonary aspergillosis in patients with hematological malignancies and prolonged neutropenia. |
| PubMedID- 22650156 | Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an aspergillus pcr assay and a galactomannan elisa in bronchoalveolar lavage samples. |
| PubMedID- 24740084 | This study was undertaken to examine the performance of the fungitell beta-glucan (bg) assay, to compare it with that of the galactomannan (gm) test for the diagnosis of invasive aspergillosis (ia) in patients with hematological malignancies, and to examine the rates of false-positive bg and gm test results due to beta-lactam antibiotics among sera of patients with gram-positive or gram-negative bacteremia and selected sera with false-positive results from the gm test. |
Page: 1